Hoffman Quoted in The Wall Street Journal About Whether Employers Can Require Employees to Get a COVID-19 Vaccine
September 18, 2020
The Wall Street Journal
Partner Carrie Hoffman was quoted in The Wall Street Journal article, “Can an Employer Require You to Get a Covid-19 Vaccine?” which examined whether private businesses can require employees to get vaccinated against COVID-19 when the vaccinations are available.
Hoffman, a labor and employment lawyer, told the WSJ that a vaccine requirement may be lawful but impractical, especially for larger companies. “It’s going to be a tough call for a lot of employers,” Hoffman said.
She says it could be time-consuming and costly for a company’s human resources to sort out individual opt-out requests. A company that mandates vaccines could also face a gross negligence suit or have to pay out a workers’ compensation claim if an inoculated employee has a severe reaction. On the flip side, it is unlikely that a company would be held legally responsible for not requiring vaccinations if no law were violated. “I don’t see how an employer would be liable for not mandating a vaccine,” she said.
Because of those complications, companies have more incentive to encourage, facilitate and subsidize vaccinations to help curb the spread of disease, she added.
People
Related News
July 21, 2025
In the News
Nicholas O'Keefe Assesses 'Golden Share' in US Steel Deal
Foley & Lardner LLP partner Nicholas O'Keefe commented on the 'golden share' arrangement included as part of the approval of Nippon Steel's acquisition of U.S. Steel in Agenda, a Financial Times publication.
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."